7-R01-EB028338-02 |
Novel imaging agents of oxidative stress in the pathophysiology of the central nervous system |
Kiel Neumann |
St. Jude Children'S Research Hospital |
5-R01-EB034607-02 |
Optical platform for functional longitudinal imaging of metabolite uptake in vivo |
Elena Goun |
University of Missouri-Columbia |
1-R41-EB034141-01 |
Optimizing the synthesis of[18F]FTMP for commercial distribution |
Mark Sellmyer |
Vellum Biosciences Llc |
5-U24-EB028941-05 |
Oxygen imaging by phosphorescence quenching |
Sergei Vinogradov |
University of Pennsylvania |
5-R21-EB030765-02 |
Para-hydrogen induced polarization of 13C labeled TCA cycle metabolite precursors |
Zoltan Kovacs |
Ut Southwestern Medical Center |
1-R21-EB034967-01 |
PET tracer for imaging senescence |
Jianghong Rao |
Stanford University |
1-R41-EB034168-01A1 |
Production of radiometal-based radiopharmaceuticals at a clinical scale via droplet-scale radiochemistry |
Jason Jones |
Dropletpharm Inc. |
4-R00-EB030602-03 |
Quantification of whole-body distribution and speciation of gadolinium-based contrast agents by Y-86 PET/MRI |
Mariane Le Fur |
Massachusetts General Hospital |
1-R21-EB033872-01 |
Rapid low-cost production of contrast agents for metabolic imaging |
Eduard Chekmenev |
Wayne State University |
5-R01-EB018378-08 |
RARE EARTH NANOPROBES FOR OPTICAL IMAGING AND DISEASE TRACKING |
Prabhas Moghe |
Rutgers, The State Univ of N.J. |